Biocon has informed that a meeting of the Board of Directors of the Company will be held on January 21, 2016, to approve the un-audited financial results for the quarter and period ended on December 31, 2015 (Q3). The Company will organize a conference call for analysts and investors on January 22, 2016.
The above information is a part of company’s filings submitted to BSE.